Berberine, pomegranate, and cinnamon extracts help balance blood sugar and reduce cravings, while chromium and L-glutamine support healthy glucose levels
Q2: Why are these dual humanized mice valuable for metabolic disease research
Dosing fundamentals Administration: Once weekly subcutaneous injection Same day each week (consistency matters) Preferably at the same time of day Half-life: Approximately 6 days, supporting weekly dosing Dose escalation: Every 4 weeks, unless: Side effects require holding current dose Individual tolerance suggests faster/slower progression Healthcare provider recommends adjustment Clinical trial doses tested The Phase 2 obesity trial tested multiple dosing arms: Key insight: 8 mg produces nearly the same results as 12 mg with fewer side effectsmaking it a potential "sweet spot" for many users
For example, the GLP-1 Program may start at $149 per month, for the first month, but the cost of the medications is not included
They mimic the natural hormone GLP-1, which: Stimulates insulin secretion Suppresses glucagon (a hormone that raises blood sugar) Delays gastric emptying (keeping you full longer) Reduces appetite via brain satiety centers This combination of effects leads to significant weight loss, improved blood sugar control, and reduced cardiovascular risks, especially when combined with lifestyle and plant-based care
Injections require a small needle stick once weekly or every two weeks, but they deliver reliable, dose-dependent results backed by years of trial data and real-world outcomes